UNITEDHEALTH GROUP INCORPORATED (Delaware) UNH
Analyst Ratings
- Consensus
- Buy — 18 Buy · 3 Hold · 0 Sell (21 analysts)
- Avg. Price Target
- $454.76 (+14.5% upside)
Key Stats
- Today's Range
- $395.20 – $402.23
- 50-Day Range
- $383.83 – $461.62
- 52-Week Range
- $236.95 – $461.62
- Volume
- 5.57 million shs
- Average Volume
- 4.27 million shs
- Market Cap
- $356.47 billion
- P/E Ratio
- 25.54
- Dividend Yield
- 2.34%
Valuation
- P/E Ratio
- 25.54
- Price / Book
- 3.41
- Price / Sales
- 0.79
Dividend
- Dividend Yield
- 2.34%
- Annual Dividend
- $9.28
- Payout Ratio
- 59.68%
- Ex-Dividend Date
- 2026-09-14
Short Interest
- Short Interest
- 0.65%
- Days to Cover
- 2.58
Financials (TTM)
- Revenue
- $450.13 billion
- Net Income
- $14.91 billion
- Net Margin
- 3.31%
- Return on Equity
- 14.27%
- Debt-to-Equity
- —
About UNITEDHEALTH GROUP INCORPORATED (Delaware)
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
Related Stocks
Compare head-to-head: UNH vs CI·UNH vs MOH·UNH vs ALHC·UNH vs CLOV
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.